AKT1 and thyroid cancer: To explore the mechanisms underlying tumor-promoting activity of N-cadherin in thyroid cancer, we tested the effect of altered expression of N-cadherin on the activities of MAPK/Erk and PI3K/Akt signaling pathways, which play key roles in thyroid cancer occurrence and progression [19].